|
|
 |
On January 8, 2005, Essential Inventions wrote to His Excellency
Mr. Urbain Olanguena Awono, the Minister of Public Health for the Republic of Cameroon,
asking the Cameroon government to approve non-voluntary licenses for any and all
patents that are relevant in Cameroon for the importation, manufacture or sale of
generic versions of the following medicines used in the treatment of HIV/AIDS:
Nevirapine (Brand name Viramune®)
Lamivudine (Brand name 3TC®)
Fixed dose combinations of Lamivudine and Zidovudine (Brand name Combivir®)
This is the January 19, 2005 press release in English
(pdf,
html),
and French
(pdf,
html).
The letter is available in English (
html,
pdf,
plain text) and French (
html,
pdf,
plain text without accents).
|